Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Safeway jumps on $4 generic bandwagon
Just two years ago, Wal-Mart started its program to sell a select list of generic prescription drugs for just $4 as part of its entry into the healthcare and pharmaceutical spaces. It looks like the retail giant kicked off a major trend.
Now Safeway plans to follow suit and be the first full grocery retailer to hop on the $4 prescription bandwagon. Target also copied Wal-Mart's assertive sales strategy, and now consumers have access to literally hundreds of generic drugs at the $4 price point, including medications for thyroid disease and hypertension, as well as antibiotics. It's a trend that's sure to please price-conscious consumers, but give headaches to drugmakers already hurt generic competition.
- read the here's the Washington Post article
- get more on this story at MSNBC
Related Articles:
Wal-Mart boosts $4 generic program
Generics beat down drug price inflation
Wal-Mart slashing generic prices
Wal-Mart expands $4 drug program, Target follows
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage


